Promising research offers hope in the fight against resistant bacteria

FHS
October 3, 2024
12:16 pm

Antibiotic resistant bacteria threaten global health. Nevertheless, few new antibiotics have come onto the market in the last 50 years.

RP-12146 by Rhizen Pharmaceuticals for Endometrial Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 19, 2024

Merck, Daiichi Sankyo to partner on targeted chemotherapy drugs in deal worth up to $22 billion

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy

October 20, 2023

With affirmative action off the table, medical schools plan new diversity tactics

“Lots of scrambling on the ground.” That’s how Consuelo Wilkins, the senior associate dean for health equity and inclusive excellence at Vanderbilt University Medical Center,

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.